Two more members added to ACIP ahead of March meetingnews2026-03-02T20:35:20+00:00March 2nd, 2026|Endpoints News|
United Therapeutics to take pulmonary hypertension drug to FDA for approvalnews2026-03-02T16:24:51+00:00March 2nd, 2026|Endpoints News|
Roche gets third pivotal win with MS drug, but liver signal could be a problemnews2026-03-02T15:25:33+00:00March 2nd, 2026|Endpoints News|
Bavarian Nordic CEO Paul Chaplin exits, months after failed $3B takeovernews2026-03-02T14:09:32+00:00March 2nd, 2026|Endpoints News|
Novartis’ Rhapsido shows promise in Phase 2 food allergy datanews2026-02-28T19:45:09+00:00February 28th, 2026|Endpoints News|
Ascendis wins FDA approval for achondroplasia drug, waits on EU actionnews2026-02-27T22:52:42+00:00February 27th, 2026|Endpoints News|
Novartis, Takeda to enter next Medicare drug price negotiationsnews2026-02-27T19:43:29+00:00February 27th, 2026|Endpoints News|
CHMP recommends Moderna’s flu-Covid shot and Novartis pill for hivesnews2026-02-27T18:16:15+00:00February 27th, 2026|Endpoints News|
Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the futurenews2026-02-27T12:11:21+00:00February 27th, 2026|Endpoints News|
DOJ urges Supreme Court to undo revival of Hikma ‘skinny label’ case news2026-02-26T20:42:26+00:00February 26th, 2026|Endpoints News|
